NDC 68084-896-95 - Venlafaxine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68084-896
- Requested NDC
- 68084-896-95
- Package NDCs from labels
- 68084-896-95, 68084-896-25
- Manufacturer
- American Health Packaging
- Effective date
- 2024-08-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Venlafaxine - American Health Packaging | American Health Packaging | 2024-08-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68084-896-25 | Venlafaxine | 30 in 1 BOX, UNIT-DOSE | TABLET | 30 | 9 | |
| 68084-896-95 | Venlafaxine | 1 in 1 BLISTER PACK | TABLET | 1 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68084-896-25 | EA - Each | 68084-896 | 923f6673-0749-4e20-adc0-178dc6bb6288 | 1 | 2015-10-02 |
| 68084-896-95 | EA - Each | 68084-896 | e45e6054-cc83-433d-b596-ee3a44e9087a | 1 | 2015-10-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| VENLAFAXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 7D7RX5A8MO | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| VENLAFAXINE | ACTIVE MOIETY | GRZ5RCB1QG | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | REMEDYREPACK INC. | ac9b972d-8b8a-4727-90c2-b208f91272fd | 2026-07-08 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Yaopharma Co., Ltd. | 38fd2c97-cd30-2f7d-e054-00144ff8d46c | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | 314277 313586 313582 313584 313580 7D7RX5A8MO |
| venlafaxine | VENLAFAXINE HYDROCHLORIDE | REMEDYREPACK INC. | 4a82cef5-693e-46e9-90c4-bff753cdce37 | 2026-07-06 | Boxed warning, Warnings, Adverse reactions | 313584 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | A-S Medication Solutions | f50029b8-7d05-445a-9d9f-71a1aee6088b | 2026-07-01 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | A-S Medication Solutions | 5a990dbd-f280-4caf-b950-4703ee98b230 | 2026-07-01 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | A-S Medication Solutions | d94e5404-f728-4e4b-af99-8a8e4dfae227 | 2026-07-01 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | A-S Medication Solutions | c37a73fa-ceee-4555-a61b-e1e66ad6e97d | 2026-07-01 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | Target Corporation | 36602b7a-99c0-f6a4-e063-6294a90a8758 | 2026-06-29 | Warnings | 1K09F3G675 |
| CalaSoothe | CALAMINE, MENTHOL, AND ZINC OXIDE | Dynarex Corporation | 54f12005-acfe-4821-e063-6394a90ac304 | 2026-06-24 | Warnings | 1K09F3G675 |
| Venlafaxine | VENLAFAXINE | St. Mary's Medical Park Pharmacy | fab65158-b2f7-1db7-e053-6294a90af231 | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | ANDA077653 313584 7D7RX5A8MO |
| VENLAFAXINE | VENLAFAXINE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 80ac757d-c629-4579-8afd-cae0ee9cd614 | 2026-06-19 | Boxed warning, Warnings, Adverse reactions | 314277 313586 313582 313584 313580 7D7RX5A8MO |
| Calamine, Pramoxind HCl | CALAMINE, PRAMOXIND HCL | H E B | 4a7a0b09-d9bc-e752-e063-6394a90a9f2c | 2026-06-15 | Warnings, Adverse reactions | 1K09F3G675 |
| Calamine, Zinc Oxide | CALAMINE, ZINC OXIDE | H E B | 4a79259e-64ac-d187-e063-6294a90a78db | 2026-06-15 | Warnings, Adverse reactions | 1K09F3G675 |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | REMEDYREPACK INC. | 7fcd7995-81fb-4368-bd4c-3726b2ae363e | 2026-06-11 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| venlafaxine | VENLAFAXINE HYDROCHLORIDE | Coupler LLC | 53e5c5a2-b8e7-3d75-e063-6294a90a508b | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | 313584 7D7RX5A8MO |
| venlafaxine | VENLAFAXINE | Coupler LLC | 53c29dd9-a4d2-7537-e063-6294a90a290f | 2026-06-08 | Boxed warning, Warnings, Adverse reactions | 314277 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Coupler LLC | 5358f20f-b864-0aae-e063-6394a90a7eab | 2026-06-03 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Coupler LLC | 5359012e-a868-3aa3-e063-6294a90a74e2 | 2026-06-03 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| venlafaxine | VENLAFAXINE | St Mary's Medical Park Pharmacy | 70d47b50-5722-3868-e053-2991aa0af85e | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | 313586 7D7RX5A8MO |
| venlafaxine | VENLAFAXINE | Coupler LLC | 52ce8a81-d7fc-cc97-e063-6394a90a5236 | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 313586 7D7RX5A8MO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.